Please use this identifier to cite or link to this item:
|Title:||Brassinin represses invasive potential of lung carcinoma cells through deactivation of PI3K/Akt/mTOR signaling cascade||Authors:||Yang, M.H.
|Issue Date:||2019||Publisher:||MDPI AG||Citation:||Yang, M.H., Lee, J.H., Ko, J.-H., Jung, S.H., Sethi, G., Ahn, K.S. (2019). Brassinin represses invasive potential of lung carcinoma cells through deactivation of PI3K/Akt/mTOR signaling cascade. Molecules 24 (8) : 1584. ScholarBank@NUS Repository. https://doi.org/10.3390/molecules24081584||Rights:||Attribution 4.0 International||Abstract:||The epithelial–mesenchymal transition (EMT) is a phenomenon that facilitates epithelial cells to acquire invasive potential to induce the initiation the metastatic spread of tumor cells. Here, we determined if brassinin (BSN) can affect the EMT process and deciphered its anti-cancer effects. BSN attenuated the levels of EMT linked genes and suppressed transforming growth factor beta (TGF-?)-mediated regulation of diverse mesenchymal markers. Additionally, BSN did increase the expression of various epithelial marker proteins in lung cancer cells. TGF-?-induced morphological changes and induction of invasive ability of tumor cells was also found to be abrogated by BSN treatment. Finally, BSN not only suppressed constitutive, but also inducible phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) phosphorylation in tumor cells. © 2019 by the authors.||Source Title:||Molecules||URI:||https://scholarbank.nus.edu.sg/handle/10635/212311||ISSN:||14203049||DOI:||10.3390/molecules24081584||Rights:||Attribution 4.0 International|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
|10_3390_molecules24081584.pdf||4.36 MB||Adobe PDF|
This item is licensed under a Creative Commons License